e-Article
Immunogenicity and safety of a booster dose of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) compared with HepB-Eng (Engerix-B®) and HepB-AS04 (Fendrix®) in adults receiving hemodialysis who previously received hepatitis B vaccination and are not seroprotected: Results of a randomized, multicenter phase 3 study
Document Type
Article
Author
Source
In: Human Vaccines and Immunotherapeutics . (Human Vaccines and Immunotherapeutics, 2022, 18(6))
Subject
Language
English
ISSN
2164554X
21645515
21645515